Precision orthotics: optimizing ankle foot orthoses to improve gait in neuromuscular diseases
- Conditions
- flaccid paresismuscle disease10029317
- Registration Number
- NL-OMON47047
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
-age between 18 and 80 years;
-weakness of the calf muscles (i.e. a MRC score <5 or unable to perform >3 heel rises);
-using an AFO or orthopedic boot (one or both sided);
-able to walk for 5 minutes, with or without walking aids;
-able to walk for 10m barefoot without assistive devices.
-presence of pes equinus under weight-bearing (dorsiflexion * 0º);
-severe deformity of the ankle/foot that cannot be fitted with a custom-made AFO;
-severe weakness of the upper legs requiring a knee-ankle-foot orthosis;
-body weight > 120 kg.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint will be walking effort (ECW), which will be measured<br /><br>during a 6-minute walk test (6MWT) with simultaneous gas-analysis. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary study endpoints will include: joint angles and net joint moments<br /><br>during gait (measured by 3D gait analysis); walking speed (assessed with a<br /><br>6MWT); perceived physical functioning (assessed with the 36-Item Short-Form<br /><br>Health Survey questionnaire); perceived fatigue (measured with the Fatigue<br /><br>Severity Scale); daily step activity (measured with the StepWatch3TM Activity<br /><br>Monitor 3.0 + a motivation dairy); and satisfaction (evaluated on a 10-point<br /><br>Numeric Rating Scale). Additional endpoints will include isometric strength and<br /><br>passive stiffness characteristics of the calf muscles; visualization of the<br /><br>fiber architecture of the calf muscles, assessed with diffusion-tensor magnetic<br /><br>resonance imaging; the AFO stiffness and treatment adherence. </p><br>